The Medicines Safety Improvement Programme (MedSIP)

The MedSIP programme aims to address the most important causes of severe harm associated with medicines, most of which have been long term challenges to the health and care system.

Harm associated with high-risk medicines in common use continue to challenge our health and care systems. The Medicines Safety Improvement Programme (MedSIP) affects safety culture and safety systems, bringing the science of continuous safety improvement to bear on this complex problem.

Programme aims

To reduce severe avoidable medication-related harm by 50% by March 2024. Eastern Patient Safety Collaborative is supporting an ICS to implement the “Whole Systems Approach to High-Risk Opioid Prescribing” change package. In 2022/23 this work is in Norfolk and Waveney ICS.

We are also rolling out an Opioid deprescribing toolkit to help support healthcare professionals to address overuse of opioids in chronic pain, based on six behavioural mechanisms identified by a research group from the University of East Anglia (and funded by NIHR ARC East of England) that support prescribers to taper opioids use.

Further information

For more information please contact Caroline Angel, Director of Patient Safety, at [email protected].

The Patient Safety Improvement Programmes are bring delivered in our region by the Eastern Patient Safety Collaborative (PSC), hosted by Eastern AHSN.

What are NatPatSIPs?

The National Patient Safety Improvement Programmes (NatPatSIPs) support a culture of safety, continuous learning and sustainable improvement across the healthcare system. They are run by the Patient Safety Collaboratives (PSCs), which are funded and nationally coordinated by NHS England and NHS Improvement and hosted locally by the Academic Health Science Networks (AHSNs).

Find out more…

Share your idea

Do you have a great idea that could make a positive health impact?

Get involved

Newsletter